Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease

[1]  R. Ramonda,et al.  Gender differences and pharmacological regulation of angiogenesis induced by synovial fluids in inflammatory arthritis. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  J. Sled,et al.  A functional cerebral endothelium is necessary to protect against cognitive decline , 2021, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Charles C. White,et al.  Multicellular communities are perturbed in the aging human brain and Alzheimer’s disease , 2020, bioRxiv.

[4]  H. Cao,et al.  Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer’s disease , 2020, Proceedings of the National Academy of Sciences.

[5]  Xiaojun Lian,et al.  Sex-dependent VEGF expression underlies variations in human pluripotent stem cell to endothelial progenitor differentiation , 2019, Scientific Reports.

[6]  Timothy J. Hohman,et al.  APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease , 2019, Neurobiology of Aging.

[7]  Bin Zhang,et al.  Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation , 2019, bioRxiv.

[8]  Timothy J. Hohman,et al.  Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer’s disease , 2019, Molecular Psychiatry.

[9]  Manolis Kellis,et al.  Single-cell transcriptomic analysis of Alzheimer’s disease , 2019, Nature.

[10]  James A. Eddy,et al.  Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach , 2019, bioRxiv.

[11]  David A Bennett,et al.  Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.

[12]  Marco Prinz,et al.  Microglial control of astrocytes in response to microbial metabolites , 2018, Nature.

[13]  S. Love,et al.  VEGFR1 and VEGFR2 in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[14]  S. Sherman,et al.  Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons , 2017, Parkinson's disease.

[15]  Mieke Dewerchin,et al.  Vascular endothelial growth factor: a neurovascular target in neurological diseases , 2016, Nature Reviews Neurology.

[16]  P. Boyle,et al.  Temporal course and pathologic basis of unawareness of memory loss in dementia , 2015, Neurology.

[17]  William T. Hu,et al.  Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study , 2015, Alzheimer's & dementia.

[18]  Timothy J. Hohman,et al.  The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease. , 2015, JAMA neurology.

[19]  C. Ruhrberg,et al.  Neuropilin regulation of angiogenesis. , 2014, Biochemical Society transactions.

[20]  J. Provias,et al.  Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease. , 2014, Current neurovascular research.

[21]  B. Longo,et al.  Therapeutic effects of the transplantation of VEGF overexpressing bone marrow mesenchymal stem cells in the hippocampus of murine model of Alzheimer’s disease , 2014, Front. Aging Neurosci..

[22]  S. Sherman,et al.  Comparative Study of the Neurotrophic Effects Elicited by Vegf- B and Gdnf in Preclinical in Vivo Models of Parkinson's Disease Nih Public Access , 2022 .

[23]  J. Jia,et al.  Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment , 2013, Neuroscience Letters.

[24]  B. Winblad,et al.  VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival , 2013, Scientific Reports.

[25]  F. Mackenzie,et al.  Emerging roles for semaphorins and VEGFs in synaptogenesis and synaptic plasticity , 2012, Cell adhesion & migration.

[26]  S. Koch,et al.  Signal transduction by vascular endothelial growth factor receptors. , 2012, Cold Spring Harbor perspectives in medicine.

[27]  Vladislav A Petyuk,et al.  Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains. , 2012, Journal of proteome research.

[28]  Ping Wang,et al.  VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. , 2011, Biochemical and biophysical research communications.

[29]  L. Claesson‐Welsh,et al.  Signal transduction by vascular endothelial growth factor receptors. , 2011, The Biochemical journal.

[30]  S. Sherman,et al.  Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease , 2011, Neuroscience Letters.

[31]  R. Dana,et al.  Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway. , 2011, Blood.

[32]  P. Carmeliet,et al.  Neuronal FLT1 receptor and its selective ligand VEGF‐B protect against retrograde degeneration of sensory neurons , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  J. Molina,et al.  The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. , 2010, Biomaterials.

[34]  Vladislav A Petyuk,et al.  Mapping protein abundance patterns in the brain using voxelation combined with liquid chromatography and mass spectrometry. , 2010, Methods.

[35]  K. Alitalo,et al.  Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3 , 2010, The Journal of cell biology.

[36]  P. Carmeliet,et al.  Role and therapeutic potential of VEGF in the nervous system. , 2009, Physiological reviews.

[37]  Y. T. Wang,et al.  Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology , 2009, The Journal of Neuroscience.

[38]  K. Becker,et al.  VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. , 2008, The Journal of clinical investigation.

[39]  G. Neufeld,et al.  Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. , 2006, Blood.

[40]  K. Jin,et al.  Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. , 2006, Developmental biology.

[41]  M. During,et al.  VEGF links hippocampal activity with neurogenesis, learning and memory , 2004, Nature Genetics.

[42]  Anders Wallin,et al.  Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia , 2002, Neurobiology of Aging.

[43]  W. Wood,et al.  Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. , 1996, Proceedings of the National Academy of Sciences of the United States of America.